Related Experiment Video
Updated: Jun 13, 2025

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
MBNL splicing factors regulate the microtranscriptome of skeletal muscles
Agnieszka Piasecka1, Michał W Szcześniak2, Michał Sekrecki1
1Laboratory of Gene Therapy, Department of Gene Expression, Institute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz University, Uniwersytetu Poznanskiego 6, 61-614 Poznań, Poland.
Abstract:
Muscleblind like splicing regulators (MBNLs) govern various RNA-processing steps, including alternative splicing, polyadenylation, RNA stability and mRNA intracellular localization. In myotonic dystrophy type 1 (DM1), the most common muscular dystrophy in adults, MBNLs are sequestered on toxic RNA containing expanded CUG repeats, which leads to disruption of MBNL-regulated processes and disease features of DM1. Herein, we show the significance of MBNLs in regulating microtranscriptome dynamics during the postnatal development of skeletal muscles and in microRNA (miRNA) misregulation observed in mouse models and patients with DM1. We identify multiple miRNAs sensitive to MBNL proteins insufficiency and reveal that many of them were postnatally regulated, which correlates with increases in the activity of these proteins during this process. In adult Mbnl1-knockout mice, miRNA expression exhibited an adult-to-newborn shift. We hypothesize that Mbnl1 deficiency influences miRNA levels through a combination of mechanisms. First, the absence of Mbnl1 protein results in alterations to the levels of pri-miRNAs. Second, MBNLs affect miRNA biogenesis by regulating the alternative splicing of miRNA primary transcripts. We propose that the expression of miR-23b, miR-27b and miR-24-1, produced from the same cluster, depends on the MBNL-sensitive inclusion of alternative exons containing miRNA sequences. Our findings suggest that MBNL sequestration in DM1 is partially responsible for altered miRNA activity. This study provides new insights into the biological roles and functions of MBNL proteins as regulators of miRNA expression in skeletal muscles.
Insights
Muscleblind like splicing regulators (MBNLs) control RNA processing. In myotonic dystrophy type 1 (DM1), MBNL sequestration disrupts microRNA (miRNA) regulation in skeletal muscles, impacting disease progression.
Area of Science:
- Molecular Biology
- Developmental Biology
- Genetics
Background:
- Muscleblind like splicing regulators (MBNLs) are crucial for RNA processing, including alternative splicing and mRNA localization.
- In myotonic dystrophy type 1 (DM1), MBNLs are sequestered by toxic CUG repeat RNA, disrupting normal cellular functions and contributing to disease pathology.
- MicroRNAs (miRNAs) play vital roles in gene regulation and are implicated in various diseases, including muscular dystrophies.
Purpose of the Study:
- To investigate the role of MBNLs in regulating microtranscriptome dynamics during postnatal skeletal muscle development.
- To elucidate the mechanisms by which MBNL deficiency leads to miRNA misregulation in DM1.
- To identify specific miRNAs affected by MBNL insufficiency and their potential contribution to DM1 pathogenesis.
Main Methods:
- Analysis of miRNA expression profiles in Mbnl1-knockout mice and DM1 patient samples.
- Investigation of MBNL protein levels and their correlation with miRNA expression during muscle development.
- Examination of pri-miRNA levels and alternative splicing events in miRNA primary transcripts.
- Functional studies on specific miRNA clusters regulated by MBNLs.
Main Results:
- MBNLs are significant regulators of miRNA expression during postnatal skeletal muscle development.
- MBNL insufficiency leads to altered miRNA levels, with an adult-to-newborn shift observed in Mbnl1-knockout mice.
- MBNL deficiency affects miRNA biogenesis through modulation of pri-miRNA levels and alternative splicing of miRNA precursors.
- Specific miRNAs, including those from the miR-23b/27b/24-1 cluster, are sensitive to MBNL levels.
Conclusions:
- MBNL sequestration in DM1 contributes to altered miRNA activity, impacting skeletal muscle function.
- MBNLs act as key regulators of the microtranscriptome in skeletal muscle, particularly during postnatal development.
- Understanding MBNL-mediated miRNA regulation provides new insights into DM1 pathogenesis and potential therapeutic strategies.
Related Concept Videos
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Regulation of Expression at Multiple Steps
Master Transcription Regulators
What is Gene Expression?

